SCHEMBL3922925

SCHEMBL3922925

O=C(O)c1ccn2cc(-c3cccc(Cl)c3)nc2c1.[NaH]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
KDM4E B2RXH2 4/20 0.53
LMNA P02545 2/20 0.53
MAPT P10636 1/20 0.53
KMT2A Q03164 1/20 0.53
RAB9A P51151 4/20 0.49
NPC1 O15118 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 1/20 0.48
MAPK1 P28482 1/20 0.48
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
GFER P55789 2/20 0.46
NR4A2 P43354 2/20 0.46
POLB P06746 1/20 0.46
KMO O15229 2/20 0.46
KDM4C Q9H3R0 1/20 0.45
HDAC1 Q13547 1/20 0.45
SUV39H2 Q9H5I1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3929582 0.99 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAMAPTKMT2A
SCHEMBL3922934 0.97 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAMAPTKMT2A
SCHEMBL3922928 0.86 ALDH1A1 (0.52) ALDH1A1KDM4ELMNAMAPTKMT2A
SCHEMBL1457799 0.85 HDAC1 (0.57) ALDH1A1KDM4ELMNARAB9ANPC1
SCHEMBL3922955 0.84 RAB9A (0.55) ALDH1A1KDM4ELMNAMAPTKMT2A
SCHEMBL5905796 0.81 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAKMT2ARAB9A
SCHEMBL25312971 0.78 KDM4E (0.71) ALDH1A1KDM4ELMNAMAPTKMT2A
SCHEMBL29466392 0.78 KDM4E (0.71) ALDH1A1KDM4ELMNAMAPTKMT2A
SCHEMBL18544548 0.77 ALDH1A1 (0.58) ALDH1A1KDM4ELMNAMAPTKMT2A
SCHEMBL6391701 0.76 RAB9A (0.69) ALDH1A1KDM4ELMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563797-B2 Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands Forest Laboratories Holding Limited (BM) 2009-07-21 US disclosed
WO-2008027812-A2 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-03-06 WO disclosed
US-20080058350-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058350-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES CNR2, CNR1, P2RY4 ALDH1A1 3141/4885KDM4E 1477/4885LMNA 4165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.